Home Care Testing Market Size, Share & Trends Analysis Report By Test Type (HIV Test Kit, Pregnancy Test, Diabetes, Glucose Tests), By Age, By Type, By Sample, By Distribution Channels, By Region, And Segment Forecasts, 2023 To 2030

The home care testing market is allowing consumers to gain control over every day well-being. Test kits that are easily accessible and affordably priced and can be purchased over the counter or online deliver quick findings without the need for conventional referrals and, in many cases, laboratories. The procedure is quick, discrete, and individualized. The kits for use at home can be used to identify a wide range of disorders, including infectious diseases, health problems, allergies, deficiency conditions, pregnancy, and drug usage. The kits range from cassettes and midstream applications to test panels, strips, and dip cards, but each is developed with affordability and ease of use.

The COVID-19 outbreak increases public awareness of the usage of self-testing kits. The pandemic raises the demand for and development of at-home test kits, including those for glucose monitoring devices, infectious diseases, and other at-home testing kits, which increases the total revenue of companies engaged in the distribution and production of testing and diagnostic devices. Companies working in the market launched various novel products to tackle the COVID-19 pandemic. For instance, in April 2021, Labcorp introduced Labcorp COVID-19 PCR Test Home Collection Kit for small businesses. This initiative aimed at providing convenient, reliable, and fast testing for entities with as many as 120 employees.

The increase in chronic disorders prevalence and the increase in the adoption of testing kits for disorder diagnosis is anticipated to boost the market growth in the coming years. According to the American Hospital Association, around 133 million individuals-around half of the U.S. population suffer from at least one chronic disease, such as heart disease, hypertension, and arthritis. Heart disorders affect over 79 million Americans and are accounted for 40% of all deaths. Moreover, the same source stated that the number of individuals with arthritis is anticipated to 67 million by 2030.

Several strategic initiatives undertaken by key entities are expected to growth opportunities for market. For instance, in October 2022, CVS Health and ixlayer entered into a partnership for branded at-home testing kits. With this test, consumers can detect vitamin D levels, Lyme disease, sexually transmitted infections and thyroid function. In December 2021, F. Hoffmann-La Roche announced that FDA approved Emergency Use Authorization to COVID-19 At-Home Test to increase access to rapid self-testing solutions in the U.S. This novel test usages a simple nasal swab sample to allow persons to self-test at home and take reliable, accurate, and quick results in 20 minutes.

Home Care Testing Market Segmentation

Major players operating in the home care testing market include Abbott, BD,Quidel Corporation, BioSure, F. Hoffmann-La Roche Ltd., Nova Biomedical, Siemens Healthcare GmbH, ACON Laboratories, Inc., OraSure Technologies, Inc., Chembio Diagnostics, Inc., and others.